All the news Showing 10 of 98 articles from: Treatment for people living with HIV and HCVGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Curing hepatitis C may reduce inflammation in people with HIV Liz Highleyman / 11 September 2019 Successful treatment of hepatitis C virus (HCV) may lead to a reduction in immune activation related to leakage of bacteria from the gut in people with HIV/HCV co-infection, according to ... Co-infection with HIV and HCV does not increase the risk of end-stage liver disease or liver cancer Keith Alcorn / 04 January 2019 People with HIV and hepatitis C are no longer at higher risk of end-stage liver disease than people with hepatitis C alone, and the trend is probably associated with the improved effectiveness ... Eliminating Hepatitis: A unique opportunity that shouldn't be missed The Parliament Magazine / 22 November 2018 Hepatitis C increases the risk of premature delivery for pregnant women with HIV Keith Alcorn / 08 November 2018 Co-infection with hepatitis C greatly increases the risk of pre-term delivery for pregnant women with HIV, Polish researchers reported last week at the International Congress on Drug Therapy in HIV Infection (HIV ... Hepatitis C elimination in people living with HIV in the UK is feasible by 2021, British HIV Association says Keith Alcorn / 10 October 2018 Hepatitis C co-infection can be eliminated in people living with HIV in the United Kingdom by 2021, the British HIV Association (BHIVA) said today. “The UK can be the first country to achieve ... Routine clinical use of DAAs highly effective and safe in people with HIV/HCV in Europe Michael Carter / 23 April 2018 “Real life” data from across Europe shows that direct-acting antivirals (DAAs) cure hepatitis C in the vast majority of people with HIV and hepatitis C virus (HCV) co-infection who receive ... 8-week course of Zepatier cures acute HCV in people with HIV Liz Highleyman / 05 April 2018 An 8-week course of grazoprevir/elbasvir (Zepatier) produced sustained virological response in most HIV-positive gay men with recent hepatitis C virus (HCV) genotype 1 or 4 infection, according to a presentation at the ... Hepatitis C treatment highly effective in harder-to-treat people with HIV co-infection, Spanish real-life study shows Michael Carter / 16 January 2018 Hepatitis C virus (HCV) treatment using direct-acting antivirals (DAAs) is highly effective and safe in harder-to-treat people with HIV co-infection, Spanish researchers report in AIDS. A sustained virological response (SVR), ... Hepatitis C test-and-treat programme reduces HCV by two-thirds among men who have sex with men in Swiss HIV Cohort Keith Alcorn / 31 October 2017 A systematic policy of test-and-treat cured 99% of men who have sex with men with hepatitis C in the Swiss HIV Cohort in an 8-month period and reduced the prevalence of hepatitis ... Gilead Sciences Announces FDA Approves Expanded Labeling for Epclusa Gilead press release / 02 August 2017 ← Prev12345...10Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Noticeboard Email bulletins News feeds